YADAY Launches Health Fund

Built to scale the next generation of health innovation

YADAY announces the launch of YADAY Health Fund, a dedicated investment platform focused on backing high-potential health and life sciences companies at the intersection of biology, AI and deep technology.

Investing from Late Seed to Series B, YADAY Health is built on a focused transatlantic thesis: identifying high-conviction health innovation across Europe and the Middle East, and helping those companies scale commercially, strategically and ultimately toward liquidity in the United States. The fund focuses on breakthrough businesses across therapeutics, AI-powered health platforms, diagnostics and clinical technologies, helping founders move from scientific validation to international growth.

YADAY Health extends YADAY’s broader cross-border investment and operating platform, built to help ambitious companies grow through capital, strategic connectivity and long-term execution.

Health as a natural next chapter

For YADAY, health is a natural extension of a broader conviction: backing businesses where deep innovation can translate into long-term economic and societal impact.

As one of the world’s largest and most strategically important sectors, healthcare stands at the intersection of scientific innovation, economic importance and technological transformation. Today, it is also one of the sectors where artificial intelligence is driving some of the deepest change: accelerating drug discovery, improving diagnostics, optimizing clinical decision-making and reshaping how healthcare systems operate with greater precision, speed and scale. Combined with advances in biology, computational science and deep technology, this is creating a new generation of health businesses built around data, scientific differentiation and scalable infrastructure.

YADAY Health will be led by Daniel Teper as Managing Partner, bringing deep experience across biotech, healthcare entrepreneurship and cross-border execution to support companies through both scientific and strategic scale. He will be supported by a strong bench of former healthcare executives, biotech and pharma operators, and domain experts with deep experience across innovation, commercialization and company building.

For YADAY, the opportunity lies not only in scientific breakthroughs, but in helping high-potential companies translate that innovation into durable healthcare businesses. YADAY Health was built to back companies where scientific depth, technological differentiation and a credible path to scale come together.

The YADAY model

That same conviction has shaped YADAY’s broader cross-border investment and operating platform. Transformative companies need more than capital. Across its investment activities, YADAY has developed a model designed to help founders scale through strategic access, operational support, investor connectivity and international execution.

YADAY Health extends this model into healthcare, combining sourcing strength across Europe and the Middle East with strategic and operational connectivity in the United States, helping portfolio companies move from scientific validation to international growth.

This includes support across US market entry, commercialization, strategic partnerships across pharma, medtech and healthcare systems, cross-border scaling, governance and long-term strategic preparation. More than an investment vehicle, YADAY Health is built as a platform to help companies move from innovation to scale.

Investing where science meets scale

YADAY Health focuses on three areas where scientific differentiation, technological innovation and scalable healthcare impact converge.

Breakthrough Therapeutics: next-generation therapies and biologically differentiated platforms addressing major unmet needs.

AI-Powered Health Platforms: scalable businesses leveraging AI across genomics, diagnostics, drug discovery and healthcare intelligence.

Clinical Technologies & Diagnostics: medical technologies and infrastructure improving precision, workflow and patient outcomes.

Early momentum

YADAY Health launches with an active pipeline across health and life sciences, including a select number of biotech opportunities currently under review. As Health Fund advances, YADAY is engaging with aligned long-term investors, strategic partners and ecosystem stakeholders across its core markets. Parties interested in learning more about YADAY Health, its investment approach and early pipeline are invited to connect with the team.

About YADAY

YADAY is a cross-border investment and operating platform supporting high-conviction companies through capital, strategic access and long-term execution. With strong connectivity across Europe, the Middle East and the United States, YADAY helps founders scale businesses across markets, sectors and growth stages.